GAITHERSBURG,, MD — Cytomedix Inc reported today in a filing with the U.S. Securities and Exchange Commission it had raised $21M in new funding. Companies file this special form with the U.S. Securities and Exchange Commission in the majority of cases when closing new funding.

Cytomedix Inc reported their revenue as between $5 - 25 million within the SEC Filing detailing the transaction. The type of investment being offered was listed as equity (opposed to debt, warrants, or other types of investment options). Cytomedix Inc noted they began raising the money on February 8, 2012. As of today, the entire $21M offering has been sold to private investors, no remaining investment is being sought at this time.

Digging into Cytomedix Inc's fundraising history, Cytomedix Inc has filed 5 fundraising documents with the U.S. Securities and Exchange Commission. Their last filing with the SEC on July 15, 2011 noted $600K in new investment. Previous to this filing, Cytomedix Inc had a $1.3M fund raise on July 15, 2011.

The SEC Filing can be viewed in its entirety by clicking here: Cytomedix Inc Form D SEC Filing.